TP53 and neoplasm: At the protein level, overexpression of TP53, WFDC2, ERBB2, and L1CAM, as well as reduced expression of estrogen and progesterone receptors (ERs/PRs), have been correlated with increased tumor aggressiveness, lymphovascular invasion, and decreased overall survival in EC [28,29,30].